# Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children

> **NCT01408537** · PHASE3 · COMPLETED · sponsor: **Mahidol University** · enrollment: 152 (actual)

## Conditions studied

- Encephalitis, Japanese B

## Interventions

- **BIOLOGICAL:** JEVAC

## Key facts

- **NCT ID:** NCT01408537
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2014-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408537, "Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01408537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*